Market Place
Sourcing Support
All News #Library
Biotech
Trojan Horse Cancer Treatment Approved For Clinical Trials
20 Jan 2026 //
GLOBENEWSWIRE
Arbor Biotech Adds Pfizer’s Mikael Dolsten to Board of Directors
25 Jun 2025 //
GLOBENEWSWIRE
Arbor Biotechnologies Appoints Don Haut as CBO
19 May 2025 //
GLOBENEWSWIRE
Arbor Biotechnologies to Present CNS Data at ASGCT Meeting
15 May 2025 //
GLOBENEWSWIRE
Arbor Biotechnologies to Present ABO-101 Data at ASGCT Meeting
13 May 2025 //
GLOBENEWSWIRE
Arbor Biotechnologies to Present Data at ASGCT 28th Annual Meeting
28 Apr 2025 //
GLOBENEWSWIRE
Arbor Biotechnologies Raises $73.9M for Gene Editing Therapeutics
18 Mar 2025 //
GLOBENEWSWIRE
Arbor Biotechnologies Announces FDA Acceptance of IND for ABO-101
19 Dec 2024 //
GLOBENEWSWIRE
Arbor Biotechnol Highlights Preclinical Data At Scientific Meetings
22 Oct 2024 //
GLOBENEWSWIRE
Arbor Biotech ABO-101, Platform Data At ASGCT 2024
09 May 2024 //
GLOBENEWSWIRE
Arbor Biotechnologies to Present at the Stifel 2023 Tailoring Genes
23 May 2023 //
GLOBENEWSWIRE
Arbor Biotechnologies Appoints Dr. Daniel Ory as Chief Medical Officer
12 Apr 2023 //
GLOBENEWSWIRE
Arbor Biotechnologies to Present at 2023 Cell & Gene Meeting on the Med
06 Apr 2023 //
GLOBENEWSWIRE
Vertex deepens gene editing ties with Arbor Bio
12 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.